1
|
Tan S, Nemeth P. Editorial: In vivo and in vitro models for research in pathology. Pathol Oncol Res 2023; 29:1611196. [PMID: 37082270 PMCID: PMC10111255 DOI: 10.3389/pore.2023.1611196] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/23/2023] [Accepted: 03/27/2023] [Indexed: 04/07/2023]
Affiliation(s)
- Songwen Tan
- Xiangya School of Pharmaceutical Sciences, Central South University, Changsha, China
- *Correspondence: Songwen Tan, ; Peter Nemeth,
| | - Peter Nemeth
- Department of Immunology and Biotechnology, University of Pécs, Medical School, Pécs, Hungary
- *Correspondence: Songwen Tan, ; Peter Nemeth,
| |
Collapse
|
2
|
Kostoff RN, Briggs MB, Kanduc D, Dewanjee S, Kandimalla R, Shoenfeld Y, Porter AL, Tsatsakis A. Modifiable contributing factors to COVID-19: A comprehensive review. Food Chem Toxicol 2023; 171:113511. [PMID: 36450305 PMCID: PMC9701571 DOI: 10.1016/j.fct.2022.113511] [Citation(s) in RCA: 3] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2022] [Revised: 11/01/2022] [Accepted: 11/03/2022] [Indexed: 11/29/2022]
Abstract
The devastating complications of coronavirus disease 2019 (COVID-19) result from an individual's dysfunctional immune response following the initial severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Multiple toxic stressors and behaviors contribute to underlying immune system dysfunction. SARS-CoV-2 exploits the dysfunctional immune system to trigger a chain of events ultimately leading to COVID-19. The current study identifies eighty immune system dysfunction-enabling toxic stressors and behaviors (hereafter called modifiable contributing factors (CFs)) that also link directly to COVID-19. Each CF is assigned to one of the five categories in the CF taxonomy shown in Section 3.3.: Lifestyle (e.g., diet, substance abuse); Iatrogenic (e.g., drugs, surgery); Biotoxins (e.g., micro-organisms, mycotoxins); Occupational/Environmental (e.g., heavy metals, pesticides); Psychosocial/Socioeconomic (e.g., chronic stress, lower education). The current study shows how each modifiable factor contributes to decreased immune system capability, increased inflammation and coagulation, and increased neural damage and neurodegeneration. It is unclear how real progress can be made in combatting COVID-19 and other similar diseases caused by viral variants without addressing and eliminating these modifiable CFs.
Collapse
Affiliation(s)
- Ronald Neil Kostoff
- Independent Consultant, Gainesville, VA, 20155, USA,Corresponding author. Independent Consultant, 13500 Tallyrand Way, Gainesville, VA, 20155, USA
| | | | - Darja Kanduc
- Dept. of Biosciences, Biotechnologies, and Biopharmaceutics, University of Bari, Via Orabona 4, Bari, 70125, Italy
| | - Saikat Dewanjee
- Advanced Pharmacognosy Research Laboratory, Department of Pharmaceutical Technology, Jadavpur University, Kolkata, 700032, India
| | - Ramesh Kandimalla
- Applied Biology, CSIR-Indian Institute of Chemical Technology, Uppal Road, Tarnaka, Hyderabad, 500007, Telangana, India
| | - Yehuda Shoenfeld
- Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, 5265601, Israel
| | - Alan L. Porter
- School of Public Policy, Georgia Institute of Technology, Atlanta, GA, 30332, USA
| | - Aristidis Tsatsakis
- Department of Forensic Sciences and Toxicology, Faculty of Medicine, University of Crete, 71003, Heraklion, Greece
| |
Collapse
|
3
|
Jeannet R, Descazeaud A, Daix T, Pauthier H, Pascal V, Hantz S, Cam SL, Francois B, Feuillard J, Lafarge X. De novo natural anti-M alloantibody emergence in severe Coronavirus Disease 2019. J Infect Public Health 2022; 15:1455-1458. [PMID: 36403401 PMCID: PMC9628129 DOI: 10.1016/j.jiph.2022.10.025] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/26/2022] [Revised: 10/25/2022] [Accepted: 10/27/2022] [Indexed: 11/05/2022] Open
Abstract
The immune response is a key player in the course of SARS-CoV-2 infection, and is often seriously dysfunctional in severe Coronavirus Disease 2019. The hyperinflammatory status has been described to be accompanied by the appearance of autoantibodies. In a lethal COVID-19 infection, we observed the emergence of a de novo natural alloantibody which targeted the M antigen from the MNS blood group on red blood cells (RBC) without evidence of any cross-reaction with SARS-CoV-2 antigens. This IgM lambda alloantibody was unmutated and unswitched. Here, we describe for the first time the emergence of a bystander de novo natural alloantibody against RBCs in a severe COVID-19 patient, highlighting the extra-follicular humoral response reported in these cases.
Collapse
Affiliation(s)
- Robin Jeannet
- INSERM CIC 1435, CHU Dupuytren, and UMR CNRS 7276 INSERM 1262, Université de Limoges, Limoges, France.
| | - Alexandra Descazeaud
- Laboratoire d'Immunohématologie, Établissement Français du Sang Nouvelle-Aquitaine, Limoges, France.
| | - Thomas Daix
- INSERM CIC 1435 and Réanimation polyvalente, CHU Dupuytren, and INSERM UMR 1092, Université de Limoges, Limoges, France.
| | - Hélène Pauthier
- Laboratoire d'Immunohématologie, Établissement Français du Sang Nouvelle-Aquitaine, Limoges, France.
| | - Virginie Pascal
- UMR CNRS 7276, INSERM 1262, Université de Limoges, and Laboratoire d'Immunologie, CHU Dupuytren, Limoges, France.
| | - Sébastien Hantz
- UMR INSERM 1092, RESINFIT, Université de Limoges, and Centre National de Référence des Herpèsvirus and Service de Bactériologie, Virologie et Hygiène, CHU Dupuytren, Limoges, France.
| | - Sophie Le Cam
- Laboratoire de qualification biologique des dons, Établissement Français du Sang Centre-Pays de la Loire, Angers, France.
| | - Bruno Francois
- INSERM CIC 1435 and Réanimation polyvalente, CHU Dupuytren, and INSERM UMR 1092, Université de Limoges, Limoges, France.
| | - Jean Feuillard
- UMR CNRS 7276 / INSERM 1262 CRIBL and Laboratoire d'Hématologie, Faculté de Médecine and CHU Dupuytren, Limoges, France.
| | - Xavier Lafarge
- INSERM U1035 Biothérapie des Maladies Génétiques, Inflammatoires et Cancers, and Direction Médicale, Établissement Français du Sang Nouvelle-Aquitaine, Bordeaux, France.
| |
Collapse
|
4
|
Coronavirus disease 2019 presenting as psychosis: a case report. J Med Case Rep 2022; 16:171. [PMID: 35459261 PMCID: PMC9026039 DOI: 10.1186/s13256-022-03349-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/17/2020] [Accepted: 02/28/2022] [Indexed: 01/08/2023] Open
Abstract
Background The coronavirus disease 2019 syndrome typically consists of respiratory symptoms and other general nonspecific symptoms. Psychotic manifestations of coronavirus disease 2019 attributable to severe acute respiratory syndrome coronavirus 2 infection are seldom reported. We report a case of coronavirus disease 2019 in a young West African male who had no known risk factors of psychiatric illness or past history of psychiatric disease presenting with acute psychosis. Case presentation Our patient, who was a young West African male, presented without the typical respiratory symptoms of coronavirus disease 2019 and also without a background history of psychiatric illness or any other significant stressors in his past or present social history. He had acute onset of psychotic symptoms consisting of visual and auditory hallucinations, delusions of persecution, and lack of insight. He was admitted and managed with antipsychotic medication and mood stabilizer. His laboratory workup was normal except for positive coronavirus disease 2019 polymerase chain reaction and his liver enzymes, which showed elevated gamma glutamyl transferase, a finding consistent with coronavirus disease 2019. His head computed tomography scan was also normal. The patient made a gradual recovery from his psychotic symptoms, with gain of insight 7 weeks after onset of symptoms, at which time his coronavirus disease 2019 test came back negative along with other laboratory parameters. He returned to work 12 weeks after his presentation and has been performing well. Conclusion Psychosis can be a primary presenting symptom in patients with coronavirus disease 2019, including those without respiratory symptoms.
Collapse
|
5
|
Singh A, Nguyen L, Everest S, Shastri P, Alemu RH. Acute Pericarditis Secondary to COVID-19 Infection. Cureus 2021; 13:e20709. [PMID: 35106244 PMCID: PMC8789202 DOI: 10.7759/cureus.20709] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 12/26/2021] [Indexed: 01/19/2023] Open
Abstract
The Coronavirus disease 2019 (COVID-19) pandemic is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Cardiac injuries are among the complications caused by COVID-19. This report presents the case of a 25-year-old patient hospitalized due to Coronavirus infection with the complication of recurrent acute pericarditis. The patient was treated with colchicine and high-dose ibuprofen, and the patient was then discharged in stable condition. This report demonstrates an effective treatment plan for acute pericarditis secondary to COVID-19 infection.
Collapse
Affiliation(s)
- Arminder Singh
- Internal Medicine, Cape Fear Valley Medical Center, Fayetteville, USA
| | - Lam Nguyen
- School of Medicine, Campbell University School of Osteopathic Medicine, Lillington, USA
| | - Stephanie Everest
- School of Medicine, Campbell University School of Osteopathic Medicine, Lillington, USA
| | - Pinang Shastri
- Cardiology, Cape Fear Valley Medical Center, Fayetteville, USA
| | - Rahel H Alemu
- Cardiology, Cape Fear Valley Medical Center, Fayetteville , USA
| |
Collapse
|